TipRanks
Go Ultimate55% OFF

Aurinia Pharmaceuticals (AUPH) Stock Forecast & Price Target

See the Price Targets and Ratings of:

AUPH Analyst Ratings

Moderate Buy
3Ratings
2Buy1Hold0Sell
Based on 3 analysts giving stock ratings to Aurinia Pharmaceuticals in the past 3 months

AUPH Stock 12 Month Forecast

$19.00▲(17.72% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $19.00 with a high forecast of $21.00 and a low forecast of $18.00. The average price target represents a 17.72% change from the last price of $16.14.
Highest Price Target$21.00Average Price Target$19.00Lowest Price Target$18.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for AUPH
Price TargetFollowArticle
Bloom Burton$21buy30.11%UpsideReiterated11/02/26
RBC Capital$16→$18hold11.52%UpsideAssigned10/30/26
TD Cowen$17→$18buy11.52%UpsideAssigned10/21/26
H.C. Wainwright$17buy5.33%UpsideReiterated02/27/26
Leerink Partners$16hold-0.87%DownsideDowngraded12/03/25
Jefferies$10→$21buy30.11%UpsideUpgraded11/07/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
REPLReplimune Group
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Aurinia Pharmaceuticals

3 Months
Stacy Ku
Stacy KuTD Cowen
Success Rate10/15 ratings generated profit
67%
Average Return
+9.93%

Copying Stacy Ku's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +9.93% per trade.

1 Year
Stacy Ku
Stacy KuTD Cowen
Success Rate12/15 ratings generated profit
80%
Average Return
+37.41%

Copying Stacy Ku's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +37.41% per trade.

2 Years
Stacy Ku
Stacy KuTD Cowen
Success Rate13/15 ratings generated profit
87%
Average Return
+57.94%

Copying Stacy Ku's trades and holding each position for 2 Years would result in 86.67% of your transactions generating a profit, with an average return of +57.94% per trade.

AUPH Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for AUPH
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy35542
Hold22231
Sell00000
Strong Sell00000
total57773

In the current month, AUPH has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. AUPH average Analyst price target in the past 3 months is 19.00.

AUPH Financial Forecast

$-1$-0.25$0.5$1.25$2Q1 2026Q3 2026Q4 2026
High$0.24
Consensus$0.21
Low$0.17

AUPH Earnings Forecast

Next quarter’s earnings estimate for AUPH is $0.21 with a range of $0.17 to $0.24. The previous quarter’s EPS was $0.23. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$77.1M$79.9M$82.7M$85.5M$88.3MQ1 2026Q3 2026Q4 2026
High$88.3M
Consensus$85.6M
Low$83.2M

AUPH Sales Forecast

Next quarter’s sales forecast for AUPH is $85.63M with a range of $83.20M to $88.30M. The previous quarter’s sales results were $83.70M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

AUPH Stock Forecast FAQ

What is AUPH’s average 12-month price target, according to analysts?
Based on analyst ratings, Aurinia Pharmaceuticals’s 12-month average price target is $19.00.
What is AUPH’s upside potential, based on the analysts’ average price target?
Aurinia Pharmaceuticals has 17.72% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AUPH a Buy, Sell or Hold?
Aurinia Pharmaceuticals has a consensus rating of Moderate Buy which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is Aurinia Pharmaceuticals’s price target?
The average price target for Aurinia Pharmaceuticals is $19.00. This is based on 3 12-month price targets, issued in the past 3 months. The highest analyst price target is $21.00, the lowest forecast is $18.00. The average price target represents a 17.72% increase from the current price of $16.14.
What do analysts say about Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of AUPH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.